Compound Summary
Compound Name: | (-)-alpha-Methylnorepinephrine |
Compound CID: | 11957514 |
Synonyms: | (-)-alpha-Methylnorepinephrine Lopac0_000359 SCHEMBL6295856 CHEMBL1320902 HMS3261G19 More... |
Iupac Name: | 4-[(1R)-2-amino-1-hydroxypropyl]benzene-1,2-diol |
InChI: | InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3/t5?,9-/m0/s1 |
InChIKey: | GEFQWZLICWMTKF-YQFNKJDISA-N |
Canonical Smiles: | CC(C(C1=CC(=C(C=C1)O)O)O)N |
Isomeric Smiles: | CC([C@@H](C1=CC(=C(C=C1)O)O)O)N |
Molecular Weight: | 183.2 |
Molecular Formula: | C9H13NO3 |
Molecular Weight: | 183.2 |
Molecular Formula: | C9H13NO3 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 13 |
Complexity: | 165 |
(-)-alpha-Methylnorepinephrine | (-)-alpha-Methylnorepinephrine |
---|---|
(-)-alpha-Methylnorepinephrine |
Lopac0_000359 |
SCHEMBL6295856 |
CHEMBL1320902 |
HMS3261G19 |
Tox21_500359 |
PDSP1_001112 |
PDSP2_001096 |
CCG-204454 |
LP00359 |
SDCCGSBI-0050347.P002 |
NCGC00093795-01 |
NCGC00093795-02 |
NCGC00093795-03 |
NCGC00093795-04 |
NCGC00093795-05 |
NCGC00093795-06 |
NCGC00261044-01 |
EU-0100359 |
Levonordefrin; (-)-3,4-Dihydroxynorephedrine |
D 5290 |
SR-01000075277 |
SR-01000075277-1 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | -3.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -3.000000000000000 | 1 | 1 |